The novel approach of the medication represents a exciting advance in the care of type 2 diabetes. Unlike existing therapies, tirzepatide affects two pathways – the GLP-1 hormone and glucose-dependent insulinotropic https://tirzepatidepeptide010106.blogchaat.com/42309115/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment